Mesoblast (MESO) Receivables - Net (2016 - 2025)
Mesoblast's (MESO) quarterly Receivables - Net came in at $43.3 million in Q4 2025, up 1345.26% year-on-year from $3.0 million in Q4 2024, and up 191.27% quarter-over-quarter from $14.9 million in Q2 2025.
Mesoblast (MESO) Receivables - Net (2016 - 2025) Analysis & Trends
Mesoblast has disclosed Receivables - Net across 10 years of filings, most recently posting $43.3 million for Q4 2025.
- Receivables - Net for Q4 2025 came in at $43.3 million, up 1345.26% year-over-year; the trailing twelve-month figure through Dec 2025 was $43.3 million (up 1345.26% YoY), and the FY2025 annual result was $14.9 million, down 29.05% from the prior year.
- Receivables - Net came in at $43.3 million for Q4 2025 at Mesoblast, up from $14.9 million in the prior quarter.
- In the past five years, Receivables - Net ranged from a high of $43.3 million in Q4 2025 to a low of $2.9 million in Q1 2021.
- The 5-year median for Receivables - Net is $5.6 million (2021), against an average of $9.3 million.
- Across the five-year window, Receivables - Net slumped 31.35% in 2022 and soared 1345.26% in 2025, its largest moves.
- Mesoblast's Receivables - Net stood at $6.0 million in 2021, then slipped by 15.43% to $5.1 million in 2022, then retreated by 21.84% to $4.0 million in 2023, then declined by 25.06% to $3.0 million in 2024, then jumped by 1345.26% to $43.3 million in 2025.
- The last three Receivables - Net figures came in at $43.3 million (Q4 2025), $14.9 million (Q2 2025), and $3.0 million (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Mesoblast | 21.68 Bn | 21.55 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 43.30 Mn |
| Dec 31, 2025 | 43.30 Mn |
| Jun 30, 2025 | 14.87 Mn |
| Jun 30, 2025 | 14.87 Mn |
| Dec 31, 2024 | 3.00 Mn |
| Dec 31, 2024 | 3.00 Mn |
| Jun 30, 2024 | 20.95 Mn |
| Jun 30, 2024 | 20.95 Mn |
| Dec 31, 2023 | 4.00 Mn |
| Dec 31, 2023 | 4.00 Mn |
| Jun 30, 2023 | 7.00 Mn |
| Jun 30, 2023 | 7.00 Mn |
| Mar 31, 2023 | 8.39 Mn |
| Mar 31, 2023 | 8.39 Mn |
| Dec 31, 2022 | 5.12 Mn |
| Dec 31, 2022 | 5.12 Mn |
| Sep 30, 2022 | 3.86 Mn |
| Sep 30, 2022 | 3.86 Mn |
| Jun 30, 2022 | 4.40 Mn |
| Jun 30, 2022 | 4.40 Mn |